Have a symptom?
See what questions
a doctor would ask.
News » PSA tests not clear on prostate cancer risk

PSA tests not clear on prostate cancer risk

Low prostate specific antigen (PSA) levels are not indicative of a clean bill of prostate health according to research that compared the effectiveness of combining the blood test with digital rectal examinations (DRE). The majority of men diagnosed with cancer of the prostate were over 70 at 11.3%, however, 5.4% of men younger than 50 were diagnosed, encouraging men of all ages to pursue prostate health check-ups.

Source: summary of medical news story as reported by Reuters Health

Related Disease Topics:

Article Source Details

About: PSA tests not clear on prostate cancer risk

Date: 28 November 2005

Source: Reuters Health


Related Medical Topics

This summary article refers to the following medical categories:

  • Risk and prostate cancer
  • Risk and cancer of the prostate
  • Risk and PSA
  • Risk and digital rectal examination
  • Risk and DRE
  • Diagnosis
  • Diagnosis and prostate cancer
  • Diagnosis and cancer of the prostate
  • Diagnosis and PSA
  • Diagnosis and prostate specific antigen
  • Diagnosis and digital rectal examination
  • Diagnosis and DRE
  • Research and male health
  • Research and prostate cancer
  • Research and cancer of the prostate
  • Research and PSA
  • Research and prostate specific antigen
  • Research and digital rectal examination
  • Research and DRE

More News Topics

  • Diet supplements may work where anti-depressants fail
  • Diet supplements need to be governed
  • Diet the key to curing ADHD problems claim author
  • Dieting can protect against Parkinson's
  • Dieting comes down to calorie consumption
  • Differences in survival rate of blood cancer explained
  • Different hypertension drug therapy combinations pose different level of risk
  • Different types of sleep disorders plague many millions of Americans
  • Digestive system disorder is gaining awareness with it's increasing prevalence amongst children
  • Disciplinary action for doctors in Nevada still pending.
  • Discovery leads to concerns about heart and eye disease drugs causing blindness
  • Disproportionate representations for participation in cancer trials
  • Diuretics and diabetes
  • Diuretics are cheap and the benefits outweigh the risks
  • DNA tests can determine if a drug is suitable for a patient

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise